FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4328103258> ?p ?o ?g. }

• W4328103258 endingPage "1234" @default.
• W4328103258 startingPage "1226" @default.
• W4328103258 abstract "Purpose To evaluate the differences in safety, effectiveness, and dosimetry between glass-based and resin-based ablative yttrium-90 (90Y) transarterial radioembolization (TARE) of hepatocellular carcinoma (HCC). Materials and Methods Using the modified Response Evaluation Criteria in Solid Tumors and Common Terminology Criteria for Adverse Events, both tumor response and adverse events (AEs) were assessed at 3 months after 90Y-TARE. Post procedure 90Y-bremsstrahlung single-photon emission computed tomography/computed tomography voxel-based dosimetry analysis was used to create tumor dose (TD) and normal tissue dose (NTD) volume histograms, and to calculate tumor particle loading and specific activity. The TD and NTD receiver operating characteristic curves evaluated the dose threshold able to predict objective (partial or complete) and complete tumor responses in addition to any-grade and grade ≥3 AE incidences. The chi-square test and Student t-test were used to assess variable differences where appropriate. Results Between 2019 and 2020, 81 patients with HCC (20 in the resin-based cohort and 61 in the glass-based cohort) underwent ablative 90Y-TARE. The resin-based cohort had more males (89% vs 65%, P = .03), lower tumor-to-normal ratio (1.81 ± 0.39 vs 2.22 ± 0.94, P = .03), higher tumor particle loading (40,172 particles/mL ± 28,039 vs 17,081 particles/mL ± 12,555, P = .0001), lower specific activity (158 Bq/particle ± 3 vs 1,058 Bq/particle ± 331, P = .001), and lower mean TD (308 Gy ± 210 vs 794 Gy ± 523, P = .0002) than the glass-based cohort. No significant differences in baseline characteristics or posttreatment AEs were noted. The overall objective and complete response rates were 85% (95% resin-based vs 82% glass-based; P = .1) and 65% (95% resin-based vs 56% glass-based; P = .003), respectively. The mean TD thresholds able to predict the objective and complete responses were 176 Gy and 247 Gy for resin-based radioembolization and 290 Gy and 481 Gy for glass-based radioembolization, respectively. A maximum NTD of 999 Gy predicted any-grade AEs in glass-based ablative 90Y-TARE. Conclusions Compared with glass-based ablative 90Y-TARE, resin-based ablative 90Y-TARE can offer comparable safety and effectiveness profiles for patients with HCC. The impact of the significantly different tumor particle loading, particle specific activities, and delivered TDs on tumor response outcomes merits further investigation." @default.
• W4328103258 created "2023-03-22" @default.
• W4328103258 creator A5006903084 @default.
• W4328103258 creator A5010786422 @default.
• W4328103258 creator A5013313674 @default.
• W4328103258 creator A5020500368 @default.
• W4328103258 creator A5065441036 @default.
• W4328103258 creator A5067244419 @default.
• W4328103258 creator A5076327694 @default.
• W4328103258 creator A5085931531 @default.
• W4328103258 date "2023-07-01" @default.
• W4328103258 modified "2023-10-01" @default.
• W4328103258 title "Yttrium-90 Radiation Segmentectomy of Hepatocellular Carcinoma: A Comparative Study of the Effectiveness, Safety, and Dosimetry of Glass-Based versus Resin-Based Microspheres" @default.
• W4328103258 cites W1546884214 @default.
• W4328103258 cites W1973076899 @default.
• W4328103258 cites W2119190881 @default.
• W4328103258 cites W2152135563 @default.
• W4328103258 cites W2347059738 @default.
• W4328103258 cites W2516758871 @default.
• W4328103258 cites W2578488156 @default.
• W4328103258 cites W2802010540 @default.
• W4328103258 cites W2898523929 @default.
• W4328103258 cites W2985871499 @default.
• W4328103258 cites W3040084298 @default.
• W4328103258 cites W3112005918 @default.
• W4328103258 cites W3127707245 @default.
• W4328103258 cites W3134234425 @default.
• W4328103258 cites W4224295285 @default.
• W4328103258 doi "https://doi.org/10.1016/j.jvir.2023.02.030" @default.
• W4328103258 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36958669" @default.
• W4328103258 hasPublicationYear "2023" @default.
• W4328103258 type Work @default.
• W4328103258 citedByCount "1" @default.
• W4328103258 countsByYear W43281032582023 @default.
• W4328103258 crossrefType "journal-article" @default.
• W4328103258 hasAuthorship W4328103258A5006903084 @default.
• W4328103258 hasAuthorship W4328103258A5010786422 @default.
• W4328103258 hasAuthorship W4328103258A5013313674 @default.
• W4328103258 hasAuthorship W4328103258A5020500368 @default.
• W4328103258 hasAuthorship W4328103258A5065441036 @default.
• W4328103258 hasAuthorship W4328103258A5067244419 @default.
• W4328103258 hasAuthorship W4328103258A5076327694 @default.
• W4328103258 hasAuthorship W4328103258A5085931531 @default.
• W4328103258 hasConcept C126322002 @default.
• W4328103258 hasConcept C126838900 @default.
• W4328103258 hasConcept C141071460 @default.
• W4328103258 hasConcept C197934379 @default.
• W4328103258 hasConcept C2776694085 @default.
• W4328103258 hasConcept C2777793932 @default.
• W4328103258 hasConcept C2778019345 @default.
• W4328103258 hasConcept C2778822529 @default.
• W4328103258 hasConcept C2779984678 @default.
• W4328103258 hasConcept C2989005 @default.
• W4328103258 hasConcept C509974204 @default.
• W4328103258 hasConcept C71924100 @default.
• W4328103258 hasConcept C72563966 @default.
• W4328103258 hasConcept C75088862 @default.
• W4328103258 hasConceptScore W4328103258C126322002 @default.
• W4328103258 hasConceptScore W4328103258C126838900 @default.
• W4328103258 hasConceptScore W4328103258C141071460 @default.
• W4328103258 hasConceptScore W4328103258C197934379 @default.
• W4328103258 hasConceptScore W4328103258C2776694085 @default.
• W4328103258 hasConceptScore W4328103258C2777793932 @default.
• W4328103258 hasConceptScore W4328103258C2778019345 @default.
• W4328103258 hasConceptScore W4328103258C2778822529 @default.
• W4328103258 hasConceptScore W4328103258C2779984678 @default.
• W4328103258 hasConceptScore W4328103258C2989005 @default.
• W4328103258 hasConceptScore W4328103258C509974204 @default.
• W4328103258 hasConceptScore W4328103258C71924100 @default.
• W4328103258 hasConceptScore W4328103258C72563966 @default.
• W4328103258 hasConceptScore W4328103258C75088862 @default.
• W4328103258 hasFunder F4320330066 @default.
• W4328103258 hasIssue "7" @default.
• W4328103258 hasLocation W43281032581 @default.
• W4328103258 hasLocation W43281032582 @default.
• W4328103258 hasOpenAccess W4328103258 @default.
• W4328103258 hasPrimaryLocation W43281032581 @default.
• W4328103258 hasRelatedWork W2037572837 @default.
• W4328103258 hasRelatedWork W2111314921 @default.
• W4328103258 hasRelatedWork W2370121646 @default.
• W4328103258 hasRelatedWork W2752827782 @default.
• W4328103258 hasRelatedWork W2782745674 @default.
• W4328103258 hasRelatedWork W2806395093 @default.
• W4328103258 hasRelatedWork W3007985759 @default.
• W4328103258 hasRelatedWork W3016104851 @default.
• W4328103258 hasRelatedWork W4232552191 @default.
• W4328103258 hasRelatedWork W4283763477 @default.
• W4328103258 hasVolume "34" @default.
• W4328103258 isParatext "false" @default.
• W4328103258 isRetracted "false" @default.
• W4328103258 workType "article" @default.